Merit Medical shares gained 3.2% after hours as Q2 revenue guidance of $380 mn -$384 mn topped estimates, marking 12%-14% YoY growth. FX headwinds may trim $2.3 mn. The upbeat outlook eased concerns over CEO Fred Lampropoulos stepping down in October, with Martha Aronson set to succeed him. Retail sentiment on Stocktwits stayed neutral.